Literature DB >> 20467850

Progression rate of neurological deficits in a 10-year cohort of SCA3 patients.

Laura Bannach Jardim1, Lisiane Hauser, Christian Kieling, Jonas Alex Morales Saute, Renan Xavier, Carlos Roberto Mello Rieder, Thais Lampert Monte, Suzi Camey, Vanessa Bielefeld Leotti Torman.   

Abstract

Spinocerebellar ataxia 3 is an untreatable CAG repeat expansion disorder whose natural history is not completely understood. Our aims were to describe the progression of neurological manifestations in a long-term cohort of spinocerebellar ataxia 3, and to verify if CAG expanded repeat, gender, and age at onset were associated with the rate of progression. Patients entered the study between 1998 and 2005 and were seen until 2007. On each visit, the validated NESSCA scale, an inventory of 18 neurological manifestations, was applied. Scores observed in each year of disease duration produced a Growth Curve, which was analyzed through the random coefficients model. Scores obtained in some individual items were described through multi-state Markov models. One hundred fifty-six patients (78 families) were recruited; 28 were lost, and 23 died. Mean (sd) ages at onset and at baseline were 32.8 (10.6) and 40.7 (12.8) years; median (range) expanded CAGn was 74 (67-85). Three hundred fifteen NESSCA evaluations were performed, comprising disease durations from zero to 34 years. The 105 patients who completed the study were seen over 5 (sd = 2.4) years at intervals of 2.5 (sd = 1.5) years. The trajectory of NESSCA obtained for the overall group increased by 1.26 points per year. This slope increased by 0.15 points per each additional CAG in the expanded repeat (p < 0.0002) and decreased by 0.03 points per each additional year of age at onset (p = 0.005). NESSCA worsened steadily, producing linear trajectories, which were faster among patients with longer expanded repeats (>74) and with lower ages at onset (<34 years).

Entities:  

Mesh:

Year:  2010        PMID: 20467850     DOI: 10.1007/s12311-010-0179-4

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  20 in total

1.  Machado-Joseph disease presenting as severe asymmetric proximal neuropathy.

Authors:  I N van Schaik; G J Jöbsis; M Vermeulen; H Keizers; P A Bolhuis; M de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C.

Authors:  Nicole M Yanjanin; Jorge I Vélez; Andrea Gropman; Kelly King; Simona E Bianconi; Sandra K Conley; Carmen C Brewer; Beth Solomon; William J Pavan; Mauricio Arcos-Burgos; Marc C Patterson; Forbes D Porter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

3.  Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.

Authors:  L B Jardim; M L Pereira; I Silveira; A Ferro; J Sequeiros; R Giugliani
Journal:  Arch Neurol       Date:  2001-06

4.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3.

Authors:  K Bürk; C Globas; S Bösch; T Klockgether; C Zühlke; I Daum; J Dichgans
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849

6.  Survival estimates for patients with Machado-Joseph disease (SCA3).

Authors:  C Kieling; P R Prestes; M L Saraiva-Pereira; L B Jardim
Journal:  Clin Genet       Date:  2007-09-25       Impact factor: 4.438

7.  The gene for Machado-Joseph disease maps to human chromosome 14q.

Authors:  Y Takiyama; M Nishizawa; H Tanaka; S Kawashima; H Sakamoto; Y Karube; H Shimazaki; M Soutome; K Endo; S Ohta
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

8.  Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?

Authors:  L Schöls; J Haan; O Riess; G Amoiridis; H Przuntek
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

9.  Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion.

Authors:  P J Tuite; E A Rogaeva; P H St George-Hyslop; A E Lang
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

10.  Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.

Authors:  A Dürr; G Stevanin; G Cancel; C Duyckaerts; N Abbas; O Didierjean; H Chneiweiss; A Benomar; O Lyon-Caen; J Julien; M Serdaru; C Penet; Y Agid; A Brice
Journal:  Ann Neurol       Date:  1996-04       Impact factor: 10.422

View more
  16 in total

1.  The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.

Authors:  H Jacobi; P Bauer; P Giunti; R Labrum; M G Sweeney; P Charles; A Dürr; C Marelli; C Globas; C Linnemann; L Schöls; M Rakowicz; R Rola; E Zdzienicka; T Schmitz-Hübsch; R Fancellu; C Mariotti; C Tomasello; L Baliko; B Melegh; A Filla; C Rinaldi; B P van de Warrenburg; C C P Verstappen; S Szymanski; J Berciano; J Infante; D Timmann; S Boesch; S Hering; C Depondt; M Pandolfo; J-S Kang; S Ratzka; J Schulz; S Tezenas du Montcel; T Klockgether
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

2.  Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.

Authors:  Karina Carvalho Donis; Jonas Alex Morales Saute; Ana Carolina Krum-Santos; Gabriel Vasata Furtado; Eduardo Preusser Mattos; Maria Luiza Saraiva-Pereira; Vanessa Leotti Torman; Laura Bannach Jardim
Journal:  Neurogenetics       Date:  2016-01-16       Impact factor: 2.660

Review 3.  Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials.

Authors:  Jonas Alex Morales Saute; Karina Carvalho Donis; Carmen Serrano-Munuera; David Genis; Luís Torres Ramirez; Pilar Mazzetti; Luis Velázquez Pérez; Pilar Latorre; Jorge Sequeiros; Antoni Matilla-Dueñas; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

4.  MR Imaging in Spinocerebellar Ataxias: A Systematic Review.

Authors:  A Klaes; E Reckziegel; M C Franca; T J R Rezende; L M Vedolin; L B Jardim; J A Saute
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

5.  Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes.

Authors:  Raphael Machado de Castilhos; Gabriel Vasata Furtado; Tailise Conte Gheno; Paola Schaeffer; Aline Russo; Orlando Barsottini; José Luiz Pedroso; Diego Z Salarini; Fernando Regla Vargas; Maria Angélica de Faria Domingues de Lima; Clécio Godeiro; Luiz Carlos Santana-da-Silva; Maria Betânia Pereira Toralles; Silvana Santos; Hélio van der Linden; Hector Yuri Wanderley; Paula Frassineti Vanconcelos de Medeiros; Eliana Ternes Pereira; Erlane Ribeiro; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

6.  Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study.

Authors:  Song Tan; Rui-Hao Wang; Hui-Xia Niu; Chang-He Shi; Cheng-Yuan Mao; Rui Zhang; Bo Song; Shi-Lei Sun; Xin-Jing Liu; Hai-Man Hou; Yu-Tao Liu; Yuan Gao; Hui Fang; Xiang-Dong Kong; Yu-Ming Xu
Journal:  Chin Med J (Engl)       Date:  2015-02-05       Impact factor: 2.628

Review 7.  Degenerative Ataxias: challenges in clinical research.

Authors:  Sub H Subramony
Journal:  Ann Clin Transl Neurol       Date:  2016-11-17       Impact factor: 4.511

8.  Variants in Genes of Calpain System as Modifiers of Spinocerebellar Ataxia Type 3 Phenotype.

Authors:  Ana Carolina Martins; Mariana Rieck; Vanessa Bielefeldt Leotti; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  J Mol Neurosci       Date:  2021-06-30       Impact factor: 3.444

9.  Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.

Authors:  Tetsuo Ashizawa; Karla P Figueroa; Susan L Perlman; Christopher M Gomez; George R Wilmot; Jeremy D Schmahmann; Sarah H Ying; Theresa A Zesiewicz; Henry L Paulson; Vikram G Shakkottai; Khalaf O Bushara; Sheng-Han Kuo; Michael D Geschwind; Guangbin Xia; Pietro Mazzoni; Jeffrey P Krischer; David Cuthbertson; Amy Roberts Holbert; John H Ferguson; Stefan M Pulst; S H Subramony
Journal:  Orphanet J Rare Dis       Date:  2013-11-13       Impact factor: 4.123

10.  The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.

Authors:  Thais Lampert Monte; Estela da Rosa Reckziegel; Marina Coutinho Augustin; Lucas D Locks-Coelho; Amanda Senna P Santos; Gabriel Vasata Furtado; Eduardo Preusser de Mattos; José Luiz Pedroso; Orlando Póvoas Barsottini; Fernando Regla Vargas; Maria-Luiza Saraiva-Pereira; Suzi Alves Camey; Vanessa Bielefeldt Leotti; Laura Bannach Jardim
Journal:  Orphanet J Rare Dis       Date:  2018-01-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.